Neuroimmunological Correlates of Circadian Rhythmicity in Oral Biology and Medicine

  • Francesco Chiappelli
  • Olivia S. Cajulis
  • Audrey Navarro
  • David R. Moradi


Sleep is a necessary behavior for physiological allostasis that is common to all vertebrates. Allostasis refers to the set of intertwined neuroendocrine-immune processes of bodily adaptation to stressful challenges during the wake cycle. The summative effects of these challenges, the allostatic load, signifies the total cost of wear and tear to the body. A finely regulated neuroimmunology of the sleep component of the circadian patterns is critical to the physiological repair mechanism required in allostasis (Solomon and Moos 1964; Solomon 1987; Sterling and Eyer 1988; Chrousos and Gold 1992; Kiecolt-Glaser, McGuire, Robles, and Glaser 2002; Irwin 2002; McEwen and Wingfield 2003; Schulkin 2003; Chiappelli and Cajulis 2004; Chiappelli et al. in press-c).


Fractal Dimension Circadian Rhythmicity Oral Squamous Cell Carcinoma Chronic Fatigue Syndrome Oral Mucositis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alvarado, Y., Bellm, L.A., and Giles, F.J. (2002) Oral mucositis: Time for more studies. Hematology 7, 281–289.PubMedCrossRefGoogle Scholar
  2. Baker, S.D. (2000) Pharmacology of fluorinated pyrimidines: Eniluracil. Invest New Drugs 18, 373–381.PubMedCrossRefGoogle Scholar
  3. Barrat, M.A., Renee, N., Mormont, M.C., Milano, G., and Levi, F. (2003) Circadian variations of dihydropyrimidine dehydrogenase (DPD) activity in oral mucosa of healthy volunteers. Pathol Biol (Paris) 51, 191–193.Google Scholar
  4. Barreda, D.R., Hanington, P.C., and Belosevic, M. (2004) Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 28, 509–554.PubMedCrossRefGoogle Scholar
  5. Bernard, F., Bossu, J.L., and Gaillard, S. (2001) Identification of living oligodendrocyte developmental stages by fractal analysis of cell morphology. J Neurosci Res 65, 439–445.PubMedCrossRefGoogle Scholar
  6. Besedovsky, H.O., and del Rey, A. (1996) Immune-neuro-endocrine interactions: Facts and hypotheses. Endocrine Rev 17, 64–102.CrossRefGoogle Scholar
  7. Blalock, J.E. (1994) The syntax of immune-neuroendocrine communication. Immunol Today 15, 504–511.PubMedCrossRefGoogle Scholar
  8. Blijlevens, N.M., Donnelly, J.P., and DePauw, B.E. (2005) Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant 36, 703–707.PubMedCrossRefGoogle Scholar
  9. Buchsel, P.C., Forgey, A., Grape, F.B., and Hamann, S.S. (2002) Granulocyte macrophage colony-stimulating factor: Current practice and novel approaches. Clin J Oncol Nurs 6, 198–205.PubMedGoogle Scholar
  10. Bulloch, K., Cullen, M.R., Schwartz, R.H., and Longo, D.L. (1987) Development of innervation within syngeneic thymus tissue transplanted under the kidney capsule of the nude mouse: A light and ultrastructural microscope study. J Neurosci Res 18, 16–27.PubMedCrossRefGoogle Scholar
  11. Burgos, J.D., and Moreno-Tovar, P. (1996) Zipf-scaling behavior in the immune system. Biosystems 39, 227–232.PubMedCrossRefGoogle Scholar
  12. Carlson, L.E., Speca, M., Patel, K.D., and Goodey E. (2004) Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 29, 448–474.PubMedCrossRefGoogle Scholar
  13. Cengiz, M., Ozyar, E., Ozturk, D., Akyol, F., Atahan, I.L., and Hayran, M. (1999) Sucralfate in the prevention of radiation-induced oral mucositis. J Clin Gastroenterol 28, 40–43.PubMedCrossRefGoogle Scholar
  14. Chiappelli, F. (2005) The molecular immunology of mucositis: Implications for evidencebased research in alternative and complementary palliative treatments. Evidence-Based Complement Altern Med 2, 489–494.CrossRefGoogle Scholar
  15. Chiappelli, F. (in press) Immunity. In: S. Vanstone, G. Chrousos, I. Craig, R. de Kloet, G. Feuerstein, B. McEwen, N. Rose, R. Rubin, and A. Steptoe (Eds.), Encyclopeadia of Stress II. Elsevier, Amsterdam.Google Scholar
  16. Chiappelli, F., Prolo, P, Cajulis, E, Harper, S., Sunga, E., and Concepcion E. (2004) Consciousness, emotional self-regulation, and the psychosomatic network: Relevance to oral biology and medicine. In: M. Beauregard (Ed.), Consciousness, Emotional Selfregulation and the Brain. Advances in Consciousness Research. John Benjamins, Philadelphia, Ch. 9, pp. 253–274.Google Scholar
  17. Chiappelli, F., and Cajulis, O.S. (2004) Psychobiological views on “stress-related oral ulcers”. Quint Int 35, 223–227.Google Scholar
  18. Chiappelli, F., Alwan, J., Prolo, P., Christensen, R., Fiala, M., Cajulis, O.S., and Bernard, G. (2005) Neuro-immunity in stress-related oral ulcerations: A fractal analysis. Front Biosci 10, 3034–3041.PubMedCrossRefGoogle Scholar
  19. Chiappelli, F., Manfrini, E., Edgerton, M., Rosenblum, M., Cajulis, K.D., and Prolo, P. (2006a) Clinical evidence and evidence-based dental treatment of special populations: Patients with Alzheimer's disease. California Dental Assoc J 34, 439–447.Google Scholar
  20. Chiappelli, F., Navarro, A.M., Moradi, D.R., Manfrini, E., and Prolo P. (2006b) Evidencebased research in complementary and alternative medicine II: Treatment of patients with Alzheimer's disease. Evidence-Based Complement Altern Med 34, 439–447.Google Scholar
  21. Chiappelli, F., Prolo, P, Fiala, M., Cajulis, O.S., Cajulis, J., Iribarren, J., Panerai, A., Neagos, N. Younai, F., and Bernard, G. (in press) Allostasis in HIV infection and AIDS. In: P.A. Minagar and P. Shapshak (Eds.), Neuro-AIDS. Nova Science Publ, Hauppauge, NY.Google Scholar
  22. Chrousos, G.P., and Gold, P.W. (1992) The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA, 267, 1244–1252.PubMedCrossRefGoogle Scholar
  23. Clarkson, J.E., Worthington, H.V., and Eden, O.B. (2003) Interventions for preventing oral mucositis for patients receiving treatment. Cochrane Database Syst Rev 3, CD000978.PubMedGoogle Scholar
  24. Clayton, F., Tessnow, K.A., Fang, J.C., Holden, J.A., and Moore, J.G. (2002) Circadian variation of topoisomerase II-alpha in human rectal crypt epithelium: Implications for reduction of toxicity of chemotherapy. Mod Pathol 15, 1191–1196.PubMedCrossRefGoogle Scholar
  25. Cross, S.S., Cotton, D.W., and Underwood, J.C. (1994) Measuring fractal dimensions. Sensitivity to edge-processing functions. Anal Quant Cytol Histol 16, 375–379.PubMedGoogle Scholar
  26. Dalgleish, A. (1999) The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines. QJM 92, 347–359.PubMedCrossRefGoogle Scholar
  27. Dou, J., Iwashita, Y., Sasaki, A., Kai, S., Hirano, S., Ohta, M., and Kitano, S. (2005) Consensus interferon enhances the anti-proliferative effect of 5-fluorouracil on human hepatoma cells via downregulation of dihydropyrimidine dehydrogenase expression. Liver Int 25, 148–152.PubMedCrossRefGoogle Scholar
  28. Duncan, M., and Grant, G. (2003) Oral and intestinal mucositis—Causes and possible treatments. Aliment Pharmacol Ther 18, 853–874.PubMedCrossRefGoogle Scholar
  29. Engle, G.L. (1960) A unified concept of health and disease. Perspect Biol Med 3, 459–485.Google Scholar
  30. Felten, D.L., Felten, S.Y., Bellinger, D.L., Carlson, S.L., Ackerman, K.D., Madden K.S., Olschowki, J.A., and Livnat S. (1987) Noradrenergic sympathetic neural interactions with the immune system: Structure and function. Immunol Rev 100, 225–260.PubMedCrossRefGoogle Scholar
  31. French, J.R.P., Rodgers, W., and Cobb, S. (1974) Adjustment as person-environment fit. In: G.V. Coelho, D.A. Hamburg, and J.E. Adams (Eds.), Coping and Adaptation. Basic Books, New York, Ch. 11.Google Scholar
  32. Fujimoto, S., Kikugawa, M., Kaneko, M., and Tamaki, N. (1992) Role of dihydropyrimidine dehydrogenase in the uridine nucleotide metabolism in the rat liver. J Nutr Sci Vitaminol 38, 39–48.PubMedGoogle Scholar
  33. Fujiwaki, R., Hata, K., Nakayama, K., Fukumoto, M., and Miyazak, K. (2000). Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer. J Clin Oncol 18, 3946–3951.PubMedGoogle Scholar
  34. Glenny, R.W., Robertson, H.T., Yamashiro, S., and Bassingthwaighte, J.B. (1991) Applications of fractal analysis to physiology. J Appl Physiol 70, 2351–2367.PubMedGoogle Scholar
  35. Gruenewald, T.L., Kemeny, M.E., and Aziz, N. (2006) Subjective social status moderates cortisol responses to social threat. Brain Behav Immun 20, 410–419.PubMedCrossRefGoogle Scholar
  36. Hoque, M.O., Kawamata, H., Nakashiro, K.I., Omotehara, F., Shinagawa, Y., Hino, S., Begum, N.M., Uchida, D., Yoshida, H., Sato, M., and Fujimori, T. (2001) Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer. Int J Oncol 19, 953–958.PubMedGoogle Scholar
  37. Irwin, M. (2002) Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun 16, 503–512.PubMedCrossRefGoogle Scholar
  38. Janjan, N.A., Weissman, D.E., and Pahule, A. (1992) Improved pain management with daily nursing intervention during radiation therapy for head and neck carcinoma. Int J Radiat Oncol Biol Phys 23, 647–652.PubMedGoogle Scholar
  39. Kabat-Zinn, J., Massion, A.O., Kristeller, J., Peterson, L.G., Fletcher, K.E., Pbert, L., Lenderking, W.R., and Santorelli, S.F. (1992) Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry 149, 936–943.PubMedGoogle Scholar
  40. Kashima, N., Ueda, M., and Kanazawa, J. (2003) Effect of 5-fluorouracil and epidermal growth factor on cell growth and dihydropyrimidine dehydrogenase regulation in human uterine cervical carcinoma SKG-IIIb cells. Cancer Sci 94, 821–825.PubMedCrossRefGoogle Scholar
  41. Keough, K.M., Hyam, P., Pink, D.A., and Quinn, B. (1991) Cell surfaces and fractal dimensions. J Microsc 163, 95–99.PubMedGoogle Scholar
  42. Kerenji, A.S., Bozovic, Z.L., Tasic, M.M., Budimlija, Z.M., Klem, I.A., and Polozovic, A.F. (2000) Fractal dimension of hepatocytes' nuclei in normal liver vs. hepatocellular carcinoma (HCC) in human subjects—Preliminary results. Arch Oncol 8, 47–50.Google Scholar
  43. Kiecolt-Glaser, J.K., McGuire, L., Robles, T.F., and Glaser, R. (2002) Psychoneuroimmunology and psychosomatic medicine: Back to the future. Psychosom Med 64, 15–28.PubMedGoogle Scholar
  44. Kubota, T. (2005) Real-time RT-PCR (TaqMan) of tumor mRNA to predict sensitivity of specimens to 5-fluorouracil. Methods Mol Med 111, 257–265.PubMedGoogle Scholar
  45. Kunz-Ebrecht, S.R., Mohamed-Ali, V., Feldman, P.J., Kirschbaum, C., and Steptoe, A. (2003) Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines. Brain Behav Immun 17, 373–383.PubMedCrossRefGoogle Scholar
  46. Kwong, K.K. (2004) Prevention and treatment of oropharyngeal mucositis following cancer therapy: Are there new approaches? Cancer Nurs 27, 183–205.PubMedCrossRefGoogle Scholar
  47. Levi, F., Soussan, A., Adam, R., Caussanel, J.P, Metzger, G., Jasmin, C., Bismuth, H., Smolensky, M., and Misset, J.L. (1995) A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer. J Infus Chemother 5, 153–158.PubMedGoogle Scholar
  48. Lorenz, E.N. (1963) Deterministic nonperiodic flow. J Atmos Sci 20, 130–141.CrossRefGoogle Scholar
  49. Losa, G.A., Baumann, G., and Nonnenmacher, T.F. (1992) Fractal dimension of pericellular membranes in human lymphocytes and lymphoblastic leukemia cells. Pathol Res Pract 188, 680–686.PubMedGoogle Scholar
  50. McEwen, B., and Wingfield, J.C. (2003) The concept of allostasis in biology and biomedicine. Hormones Behav 43, 2–15.CrossRefGoogle Scholar
  51. Mandelbrot, B. (1977) The Fractal Geometry of Nature (1st Edn.). Freeman, New York.Google Scholar
  52. Mandelbrot, B. (1986) Comment j'ai decouvert les fractales. La Recherche, 420–424.Google Scholar
  53. Mandelbrot B. (1994) A Fractal's lacunarity, and how it can be tuned and measured. In: T.F. Nonnenmacher, G.A. Losa, E.R. Weibel (Eds.), Fractals in Biology and Medicine. Birkhäuser Verlag, Basel & Boston.Google Scholar
  54. Martinsson, H.S., Starborg, M., Erlandsson, F., and Zetterberg A. (2005) Single cell analysis of G1 check points—The relationship between the restriction point and phosphorylation of pRb. Exp Cell Res 305, 383–391.PubMedCrossRefGoogle Scholar
  55. Megyeri, A., Bacso, Z., Shields, A., and Eliason, J.F. (2005) Development of a stereological method to measure levels of fluoropyrimidine metabolizing enzymes in tumor sections using laser scanning cytometry. Cytometry A 64, 62–71.PubMedGoogle Scholar
  56. Metzger, G., Massari, C., Etienne, M.C., Comisso, M., Brienza, S., Touitou, Y., Milano, G., Bastian, G., Misset, J.L., and Levi, F. (1994) Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: Relationship with mucosal toxicity in patients with cancer. Clin Pharmacol Ther 56, 190–201.PubMedCrossRefGoogle Scholar
  57. Milano, G., Fischel, J.L., Etienne, M.C., Renee, N., Formento, P., Thyss, A., Gaspard, M.H., Thill, L., and Cupissol, D. (1994) Inhibition of dihydropyrimidine dehydrogenase by alpha-interferon: Experimental data on human tumor cell lines. Cancer Chemother Pharmacol 34, 147–152.PubMedGoogle Scholar
  58. Milano, G., and Chamorey, A.L. (2002) Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics. Chronobiol Int 19, 177–189.PubMedCrossRefGoogle Scholar
  59. Miller, J.J., Fletcher, K., and Kabat-Zinn, J. (1995) Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry 17, 192–200.PubMedCrossRefGoogle Scholar
  60. Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology: Mucositis—Perspectives and Clinical Practice Guidelines–Perspectives on Cancer Therapy-Induced Mucosal Injury [online]. (2005) URL: [2005–05-04].Google Scholar
  61. Mulder, C.L. (1994) Psychosocial correlates and the effects of behavioral interventions on the course of human immunodeficiency virus infection in homosexual men. Patient Educ Couns 24, 237–247.PubMedCrossRefGoogle Scholar
  62. Naguib, F.N., Soong, S.J., and el Kouni, M.H. (1993) Circadian rhythm of orotate phosphoribosyltransferase, pyrimidine nucleoside phosphorylases and dihydrouracil dehydrogenase in mouse liver. Possible relevance to chemotherapy with 5-fluoropyrimidines. Biochem Pharmacol 45, 667–673.PubMedCrossRefGoogle Scholar
  63. Naschitz, J.E., Sabo, E., Naschitz, S., Rosner, I., Rozenbaum, M., Priselac, R.M., Gaitini, L., Zukerman, E., and Yeshurun, D. (2002) Fractal analysis and recurrence quantification analysis of heart rate and pulse transit time for diagnosing chronic fatigue syndrome. Clin Auton Res 12, 264–272.PubMedCrossRefGoogle Scholar
  64. Naumov, Y.N., Naumova, E.N., Hogan, K.T., Selin, L.K., and Gorski, J. (2003) A fractal clonotype distribution in the CD8+ memory T cell repertoire could optimize potential for immune responses. J Immunol 170, 3994–4001.PubMedGoogle Scholar
  65. Nemunaitis, J., Rosenfeld, C.S., Ash, R., Freedman, M.H., Deeg, H.J., Appelbaum, F., Singer, J.W., Flomenberg, N., Dalton, W., Elfenbein, G.J., Refkin, R., Rubin, A., Agosti, J., Hayes, F.A., Holcenberg, J., Shadduck, R.K. (1995) Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant 15, 949–954.PubMedGoogle Scholar
  66. Nonnenmacher, T.F., Baumann, G., Barth, A., and Losa, G.A. (1994) Digital image analysis of self-similar cell profiles. Int J Biomed Comput 37, 131–138.PubMedCrossRefGoogle Scholar
  67. Nygard, J.F., and Glattre, E. (2003) Fractal analysis of time series in epidemiology: Is there information hidden in the noise? Norsk Epidemiol 13, 303–308.Google Scholar
  68. Ohdo, S., Wang, D.S., Koyanagi, S., Takane, H., Inoue, K., Aramaki, H., Yukawa, E., and Higuchi, S. (2000) Basis for dosing time-dependent changes in the antiviral activity of interferon-alpha in mice. J Pharmacol Exp Ther 294, 488–493.PubMedGoogle Scholar
  69. Pierpaoli, W., and Maetroni, G.J. (1988) Neuroimmunomodulation: Some recent views and findings. Int J Neurosci 39, 165–175.PubMedGoogle Scholar
  70. Potten, C.S., Booth, D., Cragg, N.J., Tudor, G.L., O'Shea, J.A., Appleton, D., Barthel, D., Gerike, T.G., Meineke, F.A., Loeffler, M., and Booth, C. (2002) Cell kinetic studies in the murine ventral tongue epithelium: Thymidine metabolism studies and circadian rhythm determination. Cell Prolif 35S 1, 1–15.CrossRefGoogle Scholar
  71. Prolo, P., and Chiappelli, F. (in press). Immune suppression. In: S. Vanstone, G. Chrousos, I. Craig, R. de Kloet, G. Feuerstein, B. McEwen, N. Rose, R. Rubin, and A. Steptoe (Eds.), Encyclopeadia of Stress II. Elsevier, Amsterdam.Google Scholar
  72. Raida, M., Kliche, K.O., Schwabe, W., Hausler, P., Clement, J.H., Behnke, D., and Hoffken, K. (2002) Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls. J Cancer Res Clin Oncol 128, 96–102.PubMedCrossRefGoogle Scholar
  73. Rew, D.A. (1999) Tumour biology, chaos and non-linear dynamics. Eur J Surg Oncol 25, 86–89.PubMedCrossRefGoogle Scholar
  74. Robert McComb, J.J., Tacon, A., Randolph, P., and Caldera, Y. (2004) A pilot study to examine the effects of a mindfulness-based stress-reduction and relaxation program on levels of stress hormones, physical functioning, and submaximal exercise responses. J Altern Complement Med 10, 819–827.PubMedGoogle Scholar
  75. Romeo, H.E., Tio, D.L., Rahman, S.U., Chiappelli, F., and Taylor, A.N. (2001) The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: Relevance to neuroimmune surveillance of the oral cavity. J Neuroimmunol 115, 91–100.PubMedCrossRefGoogle Scholar
  76. Rose-Ped, A.M., Bellm, L.A., Epstein, J.B., Trotti, A., Gwede, C., and Fuchs, H.J. (2002) Complications of radiation therapy for head and neck cancers. The patient's perspective. Cancer Nurs 25, 461–467.PubMedCrossRefGoogle Scholar
  77. Roth, B., and Stanley, T.W. (2002) Mindfulness-based stress reduction and healthcare utilization in the inner city: Preliminary findings. Altern Ther Health Med 8, 64–66.Google Scholar
  78. Schulkin, J. (2003) Allostasis: A neural behavioral perspective. Hormones Behav 43, 21–27.CrossRefGoogle Scholar
  79. Sedivy, R., Windischberger, C., Svozil, K., Moser, E., and Breitenecker, G. (1999) Fractal analysis: An objective method for identifying atypical nuclei in dysplastic lesions of the cervix uteri. Gynecol Oncol 75, 78–83.PubMedCrossRefGoogle Scholar
  80. Solomon, G.F. (1987) Psychoneuroimmunology: Interactions between central nervous system and immune system. J Neuroscien Res 18, 1–9.CrossRefGoogle Scholar
  81. Solomon, G.F., and Moos, R.H. (1964) Emotions, immunity, and disease. Arch Gen Psychiat 11, 657–674.PubMedGoogle Scholar
  82. Sommadossi, J.P., Gewirtz, D.A., Cross, D.S., Goldman, I.D., Cano, J.P., and Diasio, R.B. (1985) Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation. Cancer Res 45, 116–121.PubMedGoogle Scholar
  83. Sterling, P., and Eyer, J. (1988) Allostasis: A new paradigm to explain arousal pathology. In: S. Fisher and J. Reason (Eds.), Handbook of Life Stress, Cognition, and Health. Wiley, New York.Google Scholar
  84. Takeda, T., Ishikawa, A., Ohtomo, K., Kobayashi, Y., and Matsuoka, T. (1992) Fractal dimension of dendritic tree of cerebellar Purkinje cell during onto- and phylogenetic development. Neurosci Res 13, 19–31.PubMedCrossRefGoogle Scholar
  85. Tuchman, M., Ramnaraine, M.L., and O'Dea, R.F. (1985) Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase. Cancer Res 45, 5553–5556.PubMedGoogle Scholar
  86. Tuchman, M., Ramnaraine, M.L., and O'Dea, R.F. (1986) In vitro degradation of pyrimidine bases: studies of rat liver dihydropyrimidine dehydrogenase. Adv Exp Med Biol 195B, 245–248.Google Scholar
  87. Ueda, M., Kitaura, K., Kusada, O., Mochizuki, Y., Yamada, N., Terai, Y., Kumagai, K., Ueki, K., and Ueki, M. (2000) Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells. Jpn J Cancer Res 91, 1185–1191.PubMedGoogle Scholar
  88. T.C., Kasperkovitz, P.V., Verbeet, N., and Verweij, C.L. (2004) Genomics in the immune system. Clin Immunol 111, 175–185.PubMedCrossRefGoogle Scholar
  89. van Kuilenburg, A.B., Meinsma, R., and van Gennip, A.H. (2004) Pyrimidine degradation defects and severe 5-fluorouracil toxicity. Nucleosides Nucleotides Nucleic Acids 23, 1371–1375.PubMedCrossRefGoogle Scholar
  90. Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., Lotsikas, A., Zachman, K., Kales, A., Wong, M.-L., Licinio, J., Prolo, P., Gold, P.W., Hermida, R.C., Mastorakos, G., and Chrousos, G.P. (1999) Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metabol 84, 2603–2607.CrossRefGoogle Scholar
  91. Watford, W.T., Hissong, B.D., Bream, J.H., Kanno, Y., Muul, L., and O'Shea, J.J. (2004) Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev. 202, 139–156.PubMedCrossRefGoogle Scholar
  92. Weissman, D.E., Janjan, N.A., and Byhardt, R.W. (1989) Assessment of pain during head and neck irradiation. J Pain Symptom Manage 4, 90–95.PubMedCrossRefGoogle Scholar
  93. Williams, K.A., Kolar, M.M., Reger, B.E., and Pearson, J.C. (2001) Evaluation of a wellnessbased mindfulness stress reduction intervention: A controlled trial. Am J Health Promot 15, 422–432.PubMedGoogle Scholar
  94. Xu, J., Lucas, R., and Wendel, A. (2004) The potential of GM-CSF to improve resistance against infections in organ transplantation. Trends Pharmacol Sci 25, 254–258.PubMedCrossRefGoogle Scholar
  95. Yao, Y., Kubota, T., Sato, K., Takeuchi, H., Kitai, R., and Matsukawa, S. (2005) Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells. J Neurooncol 72, 217–223.PubMedCrossRefGoogle Scholar
  96. Zou, L., Barnett, B., Safah, H., Larussa, V.F., Evdemon-Hogan, M., Mottram, P., Wei, S., David, O., Curiel, T.J., and Zou, W. (2004) Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res 64, 8451–8455.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Francesco Chiappelli
  • Olivia S. Cajulis
  • Audrey Navarro
  • David R. Moradi

There are no affiliations available

Personalised recommendations